DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

12 Months Ended

Dec. 31, 2015

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

5.DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to foreign currency exchange rate risks related primarily to its foreign business operations. The Company entered into forward currency exchange contracts with financial institutions to create an economic hedge to specifically manage a portion of the foreign exchange risk exposure associated with certain consolidated subsidiaries’ non-functional currency denominated assets and liabilities. All foreign currency exchange contracts entered into by the Company as of December 31, 2015 have terms of one month or less. The Company does not enter into forward currency exchange contracts for speculation or trading purposes.

The Company has not designated its foreign currency exchange contracts as hedge transactions under ASC 815. Therefore, gains and losses on the Company’s foreign currency exchange contracts are recognized in other expense, net, in the consolidated statements of income, and are largely offset by the changes in the fair value of the underlying economically hedged item.

The notional amount and fair value of all outstanding foreign currency derivative instruments in the consolidated balance sheets consist of the following at:

	December 31, 2015
Derivatives not designated as hedging instruments under FASB ASC 815-20	Notional Amount		Fair Value		Balance Sheet Location
Assets:
Foreign currency exchange contracts:
Receive USD/pay GBP	$	18,146	$	168	Accounts receivable, net
Receive USD/pay ZAR	17,411		144		Accounts receivable, net
Receive USD/pay RUB	2,173		9		Accounts receivable, net
Receive USD/pay BRL	2,478		49		Accounts receivable, net
Receive USD/pay COP	1,351		1		Accounts receivable, net
Liabilities:
Foreign currency exchange contracts:
Receive EUR/pay USD	$	39,578	$	(429)	Accrued liabilities
Receive USD/pay AUD	14,040		(82)		Accrued liabilities
Receive USD/pay CAD	2,804		(15)		Accrued liabilities
Receive USD/pay JPY	2,495		(2)		Accrued liabilities
Receive USD/pay MXN	8,122		(15)		Accrued liabilities
Receive SGD/pay USD	3,837		(30)		Accrued liabilities
Receive USD/pay NZD	1,978		(3)		Accrued liabilities
Receive USD/pay CLP	3,519		(12)		Accrued liabilities

	December 31, 2014
Derivatives not designated as hedging instruments under FASB ASC 815-20	Notional Amount		Fair Value		Balance Sheet Location
Assets:
Foreign currency exchange contracts:
Receive CAD/pay USD	$	19,940	$	83	Accounts receivable, net
Liabilities:
Foreign currency exchange contracts:
Receive EUR/pay USD	$	13,265	$	(75)	Accrued liabilities
Receive USD/pay AUD	8,343		(48)		Accrued liabilities
Receive USD/pay JPY	10,620		(84)		Accrued liabilities
Receive USD/pay ZAR	14,760		(105)		Accrued liabilities
Receive USD/pay MXN	4,961		(11)		Accrued liabilities
Receive USD/pay CLP	2,685		(10)		Accrued liabilities
Receive USD/pay COP	2,845		(2)		Accrued liabilities

The net gain on derivative instruments in the consolidated statements of income were as follows:

		Amount of gain recognized in income on derivatives
		Year ended
Derivatives not designated as hedging instruments under FASB ASC 815-20	Location of gain recognized in income on derivatives	December 31, 2015		December 31, 2014
Foreign currency exchange contracts	Other expense, net	$	2,503	$	1,424